Registry and biobank for infectious diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to create a comprehensive registry and biobank for patients with various infectious diseases, including bloodstream infections, central nervous system infections, and more. It will collect clinical, laboratory, imaging, and microbiological data to analyze the characteristics and treatment outcomes of these conditions. The study will also evaluate predictive factors for treatment success and mortality over time, contributing valuable insights into infectious disease management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with clinically suspected or microbiologically documented infectious diseases (bacterial, viral, fungal or parasitic);
* At least 18 years of age or older;
* Able to provide informed consent;
* Participants who are unable to understand the study protocol or are unable to give informed consent, but have a legal representative

Exclusion Criteria:

\- Participants who are unable to understand the study protocol or are unable to give informed consent, and have no legal representative.

Where it's running

• San Raffaele Scientific Institute
  Milan, Italy Recruiting

Study contacts

• Principal investigator: Marco Ripa, MD — IRCCS San Raffaele Scientific Institute
• Study coordinator: Elisabetta Carini
• Email: carini.elisabetta@hsr.it
• Phone: +390226437934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Al[18F]F-NOTA-folate PET imaging in suspected cardiac sarcoidosis and infective endocarditis

  This diagnostic test uses a folate-based PET tracer to see if it can help identify inflammation or infection in the heart for people with suspected cardiac sarcoidosis or infective endocarditis.

  Recruiting Turku University Hospital · Turku · NCT07814222

• Etiologic Diagnosis Algorithm in Infective Endocarditis

  Aiming to see if a combined culture and molecular testing approach can help doctors choose the right antibiotics faster for adults with infective endocarditis.

  Recruiting at 2 sites I.M. Sechenov First Moscow State Medical University · Moscow and 2 other locations · NCT07682389

• Evolution of spinal care practices in Bordeaux

  This study will track how care for spine conditions changes over five years by collecting data from adults treated for spinal issues at a Bordeaux hospital.

  Recruiting University Hospital, Bordeaux · Bordeaux · NCT07627282

• Rapid multiplex PCR test for bloodstream infections

  This project will test whether a rapid multiplex PCR test can identify pathogens and resistance genes faster than standard culture methods for hospitalized adults with positive blood cultures.

  Recruiting Istanbul Medipol University Hospital · Istanbul, Bagcılar · NCT07408544

• Rifampin-free therapy vs rifampin-containing therapy for staphylococcal prosthetic valve endocarditis

  This study tests whether a rifampin-free antibiotic regimen can be as effective as a rifampin-containing regimen for adults with staphylococcal prosthetic valve endocarditis.

  Recruiting at 29 sites Phase 3 Nantes University Hospital · Aix-les-Bains and 30 other locations · NCT07345325

• Using blood tests to identify bacteria in ICU patients with sepsis

  This study is testing a new blood test to see if it can help doctors find harmful bacteria in ICU patients with sepsis so they can better track infections and improve patient care.

  Recruiting Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan · NCT06791889

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.